Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney
Top Cited Papers
Open Access
- 1 July 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (1), 237-246
- https://doi.org/10.1016/s0002-9440(10)63292-0
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeysThe FASEB Journal, 2002
- An Anti-Inflammatory Drug, Propagermanium, May Target GPI-Anchored Proteins Associated with an MCP-1 Receptor, CCR2Journal of Interferon & Cytokine Research, 2001
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsPublished by Elsevier ,2000
- Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kB dependentKidney International, 2000
- Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-βKidney International, 1999
- Collagen Deposition in a Non-Fibrotic Lung Granuloma Model after Nitric Oxide InhibitionThe American Journal of Pathology, 1998
- Investigation of the functional role played by the chemokine monocyte chemoattractant protein‐1 in interleukin‐1‐induced murine peritonitisBritish Journal of Pharmacology, 1998
- Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritisKidney International, 1996
- Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.The Journal of Experimental Medicine, 1989
- Pathophysiology of obstructive nephropathyKidney International, 1983